Guang Shu
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 8
- Orthodontics top 2%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 12
- Cancer-related gene regulation 9
- RNA modifications and cancer 9
- Circular RNAs in diseases 6
-
- Video Surveillance and Tracking Methods 5
-
- Ferroptosis and cancer prognosis 6
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guang Shu
63 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Cancer Research 1.1k
- Complementary and Manual Therapy 112
- Orthodontics 209
- Molecular Biology 2.4k
- Computer Vision and Pattern Recognition 427
Countries citing papers authored by Guang Shu
This map shows the geographic impact of Guang Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Shu more than expected).
Fields of papers citing papers by Guang Shu
This network shows the impact of papers produced by Guang Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Shu. The network helps show where Guang Shu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guang Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 5 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 54 | |
| 9 | Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunitiesbreakdown → | 2022 | 1348 |
| 10 | 2022 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 20 | |
| 15 | 2013 | 3 | |
| 16 | A Comparative Study of Escitalopram and Citalopram in the Treatment of Depression | 2012 | 1 |
| 17 | 2011 | 41 | |
| 18 | Research on Vision-Action Model of Autonomous Robot and Obstacle Avoiding | 2003 | 2 |
| 19 | 2003 | 1 | |
| 20 | Meta-synthetic system reconstruction and applications in macro-economic researches | 2001 | 1 |
About Guang Shu
Guang Shu is a scholar working on Cancer Research, Orthodontics and Complementary and Manual Therapy, having authored 66 papers that have together received 3.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Cancer-related molecular mechanisms research (11 papers), Cancer-related gene regulation (9 papers), RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers), Ferroptosis and cancer prognosis (6 papers), Circular RNAs in diseases (6 papers) and Video Surveillance and Tracking Methods (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Complementary and Manual Therapy (112 citations) and Orthodontics (209 citations). Guang Shu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Gang Yin, Yulong Peng, Liuer He, Qing Xiao, Anqi Wu, Huiyu Li, Zhengwei Zhou, Jiani Xiao, Yuanyuan Li and Jiaqi Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.